Jubilant Pharmova Limited (BOM: 530019)

Jubilant Pharmova Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	-	9,564	10,139	9,838	5,020	12,308
Short-Term Investments	-	-	-	53.53	1,875	1,874
Cash & Short-Term Investments	9,568	9,564	10,139	9,892	6,894	14,182
Cash Growth	-5.67%	-5.67%	2.50%	43.48%	-51.39%	2.59%
Accounts Receivable	-	10,134	10,508	9,914	8,693	13,322
Other Receivables	-	2,534	1,678	1,497	1,590	2,959
Receivables	-	12,676	12,197	11,426	10,294	16,442
Inventory	-	13,038	14,215	12,861	11,429	18,792
Prepaid Expenses	-	910	900	833.54	823.74	741.59
Other Current Assets	-	2,573	173	79.99	84.63	225.82
Total Current Assets	-	38,761	37,624	35,092	29,525	50,383
Property, Plant & Equipment	-	36,871	33,652	27,911	25,752	42,875
Long-Term Investments	-	422	2,564	2,386	2,541	693.64
Goodwill	-	24,639	24,286	22,428	21,300	20,895
Other Intangible Assets	-	10,433	9,510	9,263	8,006	7,314
Long-Term Deferred Tax Assets	-	2,327	2,275	1,613	1,547	2,112
Other Long-Term Assets	-	2,029	1,652	1,211	504.39	765.6
Total Assets	-	115,485	111,567	99,909	89,181	125,217
Accounts Payable	-	8,563	8,213	5,677	5,205	10,903
Accrued Expenses	-	3,293	2,786	3,091	2,846	3,407
Short-Term Debt	-	1,965	2,583	640	200.01	6,499
Current Portion of Long-Term Debt	-	505	414	3,994	-	2,386
Current Portion of Leases	-	521	534	521.93	501.34	440.48
Current Income Taxes Payable	-	370	624	345.06	468.11	1,059
Current Unearned Revenue	-	998	719	909.81	544.6	630.75
Other Current Liabilities	-	2,675	1,851	737.41	722.98	865.15
Total Current Liabilities	-	18,890	17,724	15,916	10,488	26,190
Long-Term Debt	-	31,671	31,104	24,642	25,640	37,397
Long-Term Leases	-	1,978	2,133	2,122	1,955	1,361
Long-Term Unearned Revenue	-	5,438	2,685	72.96	75.71	82.9
Long-Term Deferred Tax Liabilities	-	2,108	3,062	3,030	2,473	2,634
Other Long-Term Liabilities	-	647	459	445.45	602.28	380.92
Total Liabilities	-	61,274	57,649	46,745	41,766	69,178
Common Stock	-	158	159	159.28	159.28	159.28
Additional Paid-In Capital	-	-	-	-	-	5,873
Retained Earnings	-	45,397	45,368	46,860	43,187	45,852
Comprensive Income & Other	-	8,784	8,466	6,166	4,069	4,155
Total Common Equity	54,339	54,339	53,993	53,186	47,415	56,039
Minority Interest	-	-128	-75	-21.63	0.31	-
Shareholders' Equity	54,211	54,211	53,918	53,164	47,415	56,039
Total Liabilities & Equity	-	115,485	111,567	99,909	89,181	125,217
Total Debt	36,640	36,640	36,768	31,920	28,296	48,084
Net Cash (Debt)	-27,072	-27,076	-26,629	-22,028	-21,401	-33,902
Net Cash Per Share	-170.96	-170.44	-167.32	-138.39	-134.37	-212.85
Filing Date Shares Outstanding	158.38	158.35	159.07	159.17	159.17	159.28
Total Common Shares Outstanding	158.38	158.35	159.07	159.17	159.17	159.28
Working Capital	-	19,871	19,900	19,176	19,037	24,193
Book Value Per Share	342.17	343.16	339.43	334.14	297.88	351.82
Tangible Book Value	19,267	19,267	20,197	21,495	18,109	27,830
Tangible Book Value Per Share	121.32	121.67	126.97	135.04	113.77	174.72
Land	-	444	440	447.86	436.86	619.36
Buildings	-	8,622	8,498	7,957	7,744	10,801
Machinery	-	32,484	29,213	26,009	21,826	38,223
Construction In Progress	-	12,523	7,733	2,918	2,778	2,636

Source: S&P Capital IQ. Standard template. Financial Sources.